Literature DB >> 29607111

Call for screening for primary aldosteronism: an underdiagnosed and treatable disease.

Leay Kiaw Er1,2, Vin-Cent Wu3.   

Abstract

Year:  2018        PMID： 29607111      PMCID： PMC5864689          DOI： 10.21037/jtd.2018.01.71

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  11 in total

1.  Prevalence and characteristics of the metabolic syndrome in primary aldosteronism.

Authors:  Francesco Fallo; Franco Veglio; Chiara Bertello; Nicoletta Sonino; Paolo Della Mea; Mario Ermani; Franco Rabbia; Giovanni Federspil; Paolo Mulatero
Journal:  J Clin Endocrinol Metab       Date:  2005-11-15       Impact factor: 5.958

2.  Risk of new-onset diabetes mellitus in primary aldosteronism: a population study over 5 years.

Authors:  Vin-Cent Wu; Shih-Chieh J Chueh; Likwang Chen; Chia-Hui Chang; Ya-Hui Hu; Yen-Hung Lin; Kwan-Dun Wu; Wei-Shiung Yang
Journal:  J Hypertens       Date:  2017-08       Impact factor: 4.844

3.  Kidney impairment in primary aldosteronism.

Authors:  Vin-Cent Wu; Shao-Yu Yang; Jou-Wei Lin; Bor-Wen Cheng; Chin-Chi Kuo; Chia-Ti Tsai; Tzong-Shinn Chu; Kuo-How Huang; Shuo-Meng Wang; Yen-Hung Lin; Chih-Kang Chiang; Hung-Wei Chang; Chien-Yu Lin; Lian-Yu Lin; Jainn-Shiun Chiu; Fu-Chang Hu; Shih-Chieh Chueh; Yi-Luwn Ho; Kao-Lang Liu; Shuei-Liong Lin; Ruoh-Fang Yen; Kwan-Dun Wu
Journal:  Clin Chim Acta       Date:  2011-02-21       Impact factor: 3.786

4.  Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma.

Authors:  Yen-Hung Lin; Lian-Yu Lin; Aaron Chen; Xue-Ming Wu; Jen-Kuang Lee; Ta-Chen Su; Vin-Cent Wu; Shih-Chieh Chueh; Wei-Chou Lin; Men-Tzung Lo; Pa-Chun Wang; Yi-Lwun Ho; Kwan-Dun Wu
Journal:  Atherosclerosis       Date:  2011-12-08       Impact factor: 5.162

Review 5.  Study Heterogeneity and Estimation of Prevalence of Primary Aldosteronism: A Systematic Review and Meta-Regression Analysis.

Authors:  Sabine C Käyser; Tanja Dekkers; Hans J Groenewoud; Gert Jan van der Wilt; J Carel Bakx; Mark C van der Wel; Ad R Hermus; Jacques W Lenders; Jaap Deinum
Journal:  J Clin Endocrinol Metab       Date:  2016-05-12       Impact factor: 5.958

6.  Risk of Fracture in Primary Aldosteronism: A Population-Based Cohort Study.

Authors:  Vin-Cent Wu; Chia-Hui Chang; Cheng-Yi Wang; Yen-Hung Lin; Tze-Wah Kao; Po-Chih Lin; Tzong-Shinn Chu; Yuan-Shian Chang; Likwang Chen; Kwan-Dun Wu; Shih-Chieh Jeff Chueh
Journal:  J Bone Miner Res       Date:  2017-02-14       Impact factor: 6.741

7.  A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.

Authors:  Gian Paolo Rossi; Giampaolo Bernini; Chiara Caliumi; Giovambattista Desideri; Bruno Fabris; Claudio Ferri; Chiara Ganzaroli; Gilberta Giacchetti; Claudio Letizia; Mauro Maccario; Francesca Mallamaci; Massimo Mannelli; Mee-Jung Mattarello; Angelica Moretti; Gaetana Palumbo; Gabriele Parenti; Enzo Porteri; Andrea Semplicini; Damiano Rizzoni; Ermanno Rossi; Marco Boscaro; Achille Cesare Pessina; Franco Mantero
Journal:  J Am Coll Cardiol       Date:  2006-11-13       Impact factor: 24.094

8.  The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.

Authors:  John W Funder; Robert M Carey; Franco Mantero; M Hassan Murad; Martin Reincke; Hirotaka Shibata; Michael Stowasser; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2016-03-02       Impact factor: 5.958

9.  Cost-Effectiveness of Screening for Primary Aldosteronism and Subtype Diagnosis in the Resistant Hypertensive Patients.

Authors:  Carrie C Lubitz; Konstantinos P Economopoulos; Stephen Sy; Colden Johanson; Heike E Kunzel; Martin Reincke; G Scott Gazelle; Milton C Weinstein; Thomas A Gaziano
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2015-11-10

10.  Long term outcome of Aldosteronism after target treatments.

Authors:  Vin-Cent Wu; Shuo-Meng Wang; Chia-Hui Chang; Ya-Hui Hu; Lian-Yu Lin; Yen-Hung Lin; Shih-Chieh Jeff Chueh; Likwang Chen; Kwan-Dun Wu
Journal:  Sci Rep       Date:  2016-09-02       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.